Relmada Therapeutics (RLMD)

Relmada Therapeutics (RLMD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• RLMD last traded at $3.58, 4.07% on the day.
• Relmada Therapeutics: market cap $381.88M, P/E -4.2, next earnings 2026-11-12.
• Over the past year RLMD returned 54.31%; year to date -25.88%.

Updated 2026-11-03 02:01 UTC